Personalis, Inc. (PSNL)
Personalis, Inc. operates globally as a specialized cancer genomics firm. The company delivers advanced sequencing and data analysis capabilities, primarily supporting the development of novel cancer treatments and facilitating extensive genetic research initiatives. Central to their offerings is the NeXT Platform, which enables detailed data analysis of tumors and their surrounding immune microenvironments, even from small tissue or plasma samples. This platform encompasses several specialized solutions: ImmunoID Next for tissue-based tumor profiling; NeXT Liquid Biopsy for plasma analysis; NeXT Personal, a specific liquid biopsy designed for individual patient tumor tracking; the NeXT Dx Test, a genomic cancer profiling tool that identifies composite biomarkers for treatment guidance; and the sophisticated NeXT SHERPA and NeXT NEOPS for predicting neoantigens. Additionally, Personalis offers the ACE platform, utilized for diverse clinical and therapeutic applications like neoantigen prediction, biomarker identification, and the selection of new drug targets. Their clientele includes biopharmaceutical companies, academic institutions, non-profit organizations, and government entities. The company has established significant partnerships with organizations such as Mayo Clinic, MapKure, LLC, SpringWorks Therapeutics, Inc., and Moores Cancer Center. Personalis, Inc. was founded in 2011 and is based in Menlo Park, California.
Sector: Services-Medical Laboratories
Industry: Medical - Diagnostics & Research
Personalis, Inc.
NASDAQ:PSNLHealthcare · Medical - Diagnostics & Research
-0.66%$15.82
AH$15.82+0.00%vs close
Mkt Cap$1.69B
Float67.27M
O/S106.8M
Vol
$ Vol
RVOL
Inst Own79.2%
SI10.1%
Earnings
Dilution
Financials Summary
Revenue$69.65M
Net Income-$81.27M
Total Assets$334.16M
Free Cash Flow-$79.45M
Debt & Equity
Debt 13%
Equity 87%
Total Debt$39.95M
Total Equity$261.19M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in PSNL's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$334.16M
Liabilities$72.98M
Accounts Receivable$16.2M
Accounts Payable$12.99M
Inventory$6.14M
PP&E (Net)$59.93M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $69.65M | $84.61M | $73.48M | $65.05M | $85.49M | $78.65M | $65.21M | $37.77M | $9.39M |
| YoY Growth | -17.7% | 15.2% | 13.0% | -23.9% | 8.7% | 20.6% | 72.6% | 302.2% | - |
| Cost of Revenue | $53.87M | $57.79M | $55.27M | $51.7M | $53.84M | $58.53M | $43.13M | $25.97M | $11.74M |
| Gross Profit | $15.78M | $26.82M | $18.21M | $13.35M | $31.66M | $20.11M | $22.08M | $11.8M | -$2.34M |
| Gross Margin | 22.7% | 31.7% | 24.8% | 20.5% | 37.0% | 25.6% | 33.9% | 31.3% | -24.9% |
| Research and Development | $50.26M | $48.91M | $64.78M | $64.91M | $49.31M | $28.57M | $22.42M | $14.3M | $9.92M |
| Selling, General, and Administrative | $53.57M | $46.19M | $49.73M | $63.97M | $47.7M | $33.69M | $22.08M | $11.27M | $9.9M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$33K | $0 |
| Total Operating Expenses | $103.83M | $95.09M | $114.5M | $128.88M | $97.01M | $62.26M | $44.5M | $25.57M | $19.82M |
| Operating Income (EBIT) | -$88.06M | -$68.27M | -$96.29M | -$115.53M | -$65.35M | -$42.15M | -$22.42M | -$13.77M | -$22.16M |
| Operating Margin | -126.4% | -80.7% | -131.0% | -177.6% | -76.4% | -53.6% | -34.4% | -36.5% | -236.0% |
| Interest Expense | $205K | $24K | $110K | $201K | $184K | $2K | $1.13M | $1.89M | $1.3M |
| Interest Income | $7.16M | $5.51M | $5.9M | $2.4M | $367K | $949K | $1.62M | $293K | $100K |
| Other Income (Expense) | $6.81M | -$13M | -$11.92M | $2.26M | $141K | $923K | -$2.66M | -$6.11M | -$1.43M |
| Income Before Tax (EBT) | -$81.25M | -$81.27M | -$108.21M | -$113.28M | -$65.21M | -$41.22M | -$25.07M | -$19.88M | -$23.59M |
| Income Tax Expense | $21K | $18K | $83K | $40K | $14K | $57K | $9K | $7K | $5K |
| Net Income | -$81.27M | -$81.28M | -$108.3M | -$113.31M | -$65.23M | -$41.28M | -$25.08M | -$19.89M | -$23.6M |
| Net Income Margin | -116.7% | -96.1% | -147.4% | -174.2% | -76.3% | -52.5% | -38.5% | -52.6% | -251.2% |
| Supplementary Data | |||||||||
| EPS | -0.91 | -1.37 | -2.25 | -2.48 | -1.49 | -1.20 | -1.39 | -0.91 | -1.08 |
| Diluted EPS | -0.91 | -1.37 | -2.25 | -2.48 | -1.49 | -1.20 | -1.39 | -0.91 | -1.08 |
| Weighted Average OS | 89.24M | 59.25M | 48.18M | 45.70M | 43.89M | 34.37M | 18.01M | 21.75M | 21.75M |
| EBITDA | -$71M | -$70.3M | -$96.81M | -$104.64M | -$59.01M | -$35.46M | -$19.19M | -$14.92M | -$21.07M |
| EBITDA Margin | -101.9% | -83.1% | -131.7% | -160.9% | -69.0% | -45.1% | -29.4% | -39.5% | -224.4% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and Cash Equivalents | $124.25M | $91.42M | $56.98M | $89.13M | $105.58M | $68.53M | $55.05M | $19.74M | $22.62M |
| Short-Term Investments | $115.71M | $93.59M | $57.2M | $78.53M | $181.48M | $134.76M | $73.24M | $0 | $0 |
| Cash and Short-Term Investments | $239.95M | $185.01M | $114.18M | $167.66M | $287.06M | $203.29M | $128.29M | $19.74M | $22.62M |
| Accounts Receivable | $16.2M | $8.14M | $17.73M | $16.64M | $18.47M | $6.35M | $3.3M | $4.46M | $1.94M |
| Inventory | $6.14M | $3.98M | $5.66M | $6.38M | $4.08M | $2.67M | $1.42M | $2.13M | $822K |
| Other Current Assets | $5.65M | $5.89M | $9.17M | $9.02M | $1.53M | $2.96M | $3.18M | $1.3M | $542K |
| Total Current Assets | $267.95M | $203.01M | $146.74M | $199.7M | $318.23M | $220.72M | $139.58M | $29.56M | $26.73M |
| Long-Term Assets | |||||||||
| Property, Plant & Equipment Net | $59.93M | $64.73M | $75.22M | $88.42M | $73.47M | $22.11M | $15.95M | $11.45M | $6.34M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $6.28M | $2.53M | $3.14M | $4.59M | $4.83M | $2.02M | $1.76M | $659K | $495K |
| Total Long-Term Assets | $66.21M | $67.25M | $78.36M | $93M | $78.3M | $24.12M | $17.71M | $12.11M | $6.84M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $334.16M | $270.27M | $225.1M | $292.7M | $396.53M | $244.84M | $157.29M | $41.67M | $33.56M |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | $12.99M | $6.4M | $14.92M | $12.85M | $9.22M | $8.3M | $7.34M | $6.57M | $4.04M |
| Short-Term Debt | $1.19M | $1.67M | $1.65M | $2.22M | $1.81M | $0 | $0 | $5M | $17.51M |
| Current Income Tax Payable | $0 | $0 | $37K | $123K | $121K | $95K | $210K | $181K | $108K |
| Current Unearned Revenue | $1.56M | $3.1M | $3.29M | $1.29M | $4.36M | $21.03M | $35.98M | $42.9M | $24.71M |
| Other Current Liabilities | $12.8M | $10.86M | $19.62M | $9.55M | $11.19M | $8.45M | $4.39M | $43.18M | $718K |
| Total Current Liabilities | $39.63M | $31.13M | $47.23M | $33.13M | $31.31M | $40.64M | $49.96M | $57.85M | $48.99M |
| Long-Term Liabilities | |||||||||
| Long-Term Debt | $31.87M | $0 | $0 | $0 | $0 | $0 | $0 | $683K | $292K |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $1.48M | $1.3M | $10.1M | $389K | $2.12M | $720K | $0 | $89.53M | $76.89M |
| Total Long-Term Liabilities | $33.35M | $36.19M | $48.42M | $41.43M | $54.91M | $9.26M | $639K | $90.21M | $77.18M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $72.98M | $67.31M | $95.66M | $74.56M | $86.23M | $49.9M | $50.6M | $148.06M | $126.17M |
| Stockholders' Equity | |||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $89.4M | $76M |
| Common Stock | $10K | $9K | $5K | $5K | $4K | $4K | $3K | $1K | $1K |
| Retained Earnings | -$631.26M | -$549.99M | -$468.71M | -$360.41M | -$247.09M | -$181.87M | -$140.59M | -$115.5M | -$95.62M |
| Comprehensive Income & Other | $104K | -$23K | -$222K | -$912K | -$166K | $22K | -$6K | -$15K | -$10K |
| Other Stockholders' Equity | $892.43M | $752.94M | $598.14M | $578.54M | $557.39M | $376.81M | $247.28M | $9.12M | $3.02M |
| Total Equity | $261.19M | $202.96M | $129.44M | $218.14M | $310.3M | $194.94M | $106.69M | -$106.39M | -$92.6M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $334.16M | $270.27M | $225.1M | $292.7M | $396.53M | $244.84M | $157.29M | $41.67M | $33.56M |
| Supplementary Data | |||||||||
| Total Debt | $39.95M | $44.25M | $47.73M | $48.65M | $58.33M | $10.99M | $2M | $5M | $17.51M |
| Net Debt | -$84.3M | -$47.17M | -$9.26M | -$40.48M | -$47.25M | -$57.54M | -$53.05M | -$14.75M | -$5.11M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Operating Activities | |||||||||
| Net Income | -$81.27M | -$81.28M | -$108.3M | -$113.31M | -$65.23M | -$41.28M | -$25.08M | -$19.89M | -$23.6M |
| Depreciation & Amortization | $10.05M | $10.94M | $11.3M | $8.43M | $6.01M | $5.76M | $4.75M | $3.07M | $1.22M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $2.03M | $391K | $3.11M | $4.47M | $226K |
| Stock-Based Compensation | $9.43M | $10.69M | $14.05M | $19.43M | $14.38M | $8.24M | $4.86M | $1.32M | $753K |
| Changes in Working Capital: | |||||||||
| Accounts Receivable | -$8.06M | $9.59M | -$1.09M | $1.82M | -$12.12M | -$3.05M | $1.07M | -$2.52M | -$1.2M |
| Inventory | -$204K | $4.42M | -$1.93M | -$2.98M | $29K | -$1.08M | -$1.17M | -$2.07M | -$539K |
| Accounts Payable | $4.55M | -$8.92M | $5.18M | $3.09M | -$1.46M | $751K | $1.4M | $2.16M | $2.63M |
| Other Working Capital | -$6.48M | -$7.68M | $11.33M | $8.68M | -$17.6M | -$13.86M | -$8.56M | $17.84M | $19.87M |
| Total Working Capital Change | -$10.19M | -$2.59M | $13.48M | $10.61M | -$31.14M | -$17.23M | -$7.26M | $15.42M | $20.76M |
| Other Non-Cash Items | -$2.96M | $17.1M | $13.21M | $4.61M | $3.12M | $1.47M | $1.56M | $1.18M | $934K |
| Net Cash from Operating | -$74.95M | -$45.15M | -$56.26M | -$70.23M | -$70.83M | -$42.65M | -$18.07M | $5.57M | $290K |
| Investing Activities | |||||||||
| Capital Expenditures | -$4.5M | -$1.6M | -$10.91M | -$49.9M | -$11.08M | -$3.25M | -$8.38M | -$7.85M | -$5.16M |
| Acquisitions | $0 | $0 | -$24.01M | $0 | $48.99M | $65.14M | $73.2M | $0 | $0 |
| Purchases of Investments | -$210.17M | -$121.71M | -$103.94M | -$121.49M | -$267.13M | -$161.78M | -$78.9M | $0 | $0 |
| Sales of Investments | $192.11M | $88M | $127.95M | $223.92M | $218.14M | $99.88M | $5.7M | $0 | $0 |
| Other Investing Activities | $0 | $242K | $24.01M | $0 | -$48.99M | -$65.14M | -$73.2M | $0 | $0 |
| Net Cash from Investing | -$22.57M | -$35.07M | $13.1M | $52.54M | -$60.07M | -$65.14M | -$81.58M | -$7.85M | -$5.16M |
| Financing Activities | |||||||||
| Debt Repaid | -$585K | $1.13M | -$174K | $1.1M | -$3.31M | - | $5M | $645K | -$16.4M |
| Common Stock Issuance | $129.94M | $97.82M | $3.51M | $2.46M | $162.26M | $117.5M | $144.03M | $54K | $65K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$189K | $17.98M | $7.34M | $0 | $4.13M | $3.77M | -$4.08M | $54K | $2K |
| Net Cash from Financing | $130.34M | $114.67M | $11.03M | $1.37M | $169.7M | $121.27M | $134.95M | -$591K | $16.4M |
| Forex Effect | $6K | -$22K | -$16K | -$127K | $47K | $7K | $2K | -$2K | $4K |
| Net Change in Cash | $32.83M | $34.43M | -$32.14M | -$16.46M | $38.85M | $13.48M | $35.3M | -$2.87M | $11.54M |
| Supplementary Data | |||||||||
| Operating Cash Flow | -$74.95M | -$45.15M | -$56.26M | -$70.23M | -$70.83M | -$42.65M | -$18.07M | $5.57M | $290K |
| Capital Expenditure | -$4.5M | -$1.6M | -$10.91M | -$49.9M | -$11.08M | -$3.25M | -$8.38M | -$7.85M | -$5.16M |
| Free Cash Flow | -$79.45M | -$46.75M | -$67.17M | -$120.13M | -$81.91M | -$45.9M | -$26.45M | -$2.28M | -$4.87M |
| Cash at Beginning | $93.2M | $58.77M | $89.13M | $107.38M | $68.53M | $55.05M | $19.74M | $22.62M | $11.08M |
| Cash at End | $126.03M | $93.2M | $56.98M | $90.92M | $107.38M | $68.53M | $55.05M | $19.74M | $22.62M |